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Abstract
Varicella zoster virus (VZV) ORF25 is a 156 amino acid protein belonging to the approximately
40 core proteins that are conserved throughout the Herpesviridae. By analogy to its functional
orthologue UL33 in Herpes simplex virus 1 (HSV-1), ORF25 is thought to be a component of the
terminase complex. To investigate how cleavage and encapsidation of viral DNA links to the
nuclear egress of mature capsids in VZV, we tested ten VZV proteins that are predicted to be
involved in either of the two processes for protein interactions against each other using three
independent protein-protein interaction (PPI) detection systems: the yeast-two-hybrid (Y2H)
system, a luminescence based MBP pull-down interaction screening assay (LuMPIS) and a
bioluminescence resonance energy transfer (BRET) assay. A set of 20 interactions was
consistently detected by >2 methods and resulted in a dense interaction network between proteins
associated in encapsidation and nuclear egress. The results indicate that the terminase complex in
VZV consists of ORF25, ORF30 and ORF45/42, and support a model in which both processes are
closely linked to each other. Consistent with its role as a central hub for protein interactions,
ORF25 is shown to be essential for VZV replication.
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varicella zoster virus; ORF25; encapsidation; nuclear egress complex; LuMPIS; BRET; Y2H;
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INTRODUCTION
Varicella-zoster virus (VZV) causes chickenpox upon primary infection and establishes
latency in the dorsal root ganglia, from where it may reactivate causing herpes zoster. As a
member of the α-Herpesviruses VZV belongs to the most complex viruses known. The
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virion particles consist of a double-stranded (ds) DNA genome packaged into a
nucleocapsid, a proteinaceous matrix called the tegument, and a cell-derived lipid
envelope 1. The dsDNA replication of α-herpesviruses is believed to follow a rolling-circle
mechanism, where concatemers of genomes arranged in a head-to-tail fashion are formed.
The cleavage of single genomes is tightly coupled to their energy-dependent packaging into
precapsids, a process mediated by multi-protein complexes, which resembles the packaging
of genomes in the tailed dsDNA bacteriophages 1, 2. In HSV-1, at least seven proteins are
known to be responsible for these processes: UL6, UL15, UL17, UL25, UL28, UL32 and
UL33 3, 4. Three of them, HSV-1 UL15, UL28 and UL33 have been shown to interact with
each other and are considered to form the terminase complex 5, 6. Deletion of these genes is
lethal as the viruses are not able to package the dsDNA into the capsid 4, 7, 8.
VZV ORF25, the orthologue of HSV-1 UL33, is a 156 aa protein which belongs to a set of
approximately 40 core proteins that are conserved throughout the Herpesviridae. In HSV-1,
UL33 has been shown to be essential and involved in DNA packaging 3, 4, 9. Within a
comprehensive Y2H analysis of the VZV protein interaction network, we previously showed
that VZV ORF25 constitutes a central hub interacting with many other VZV proteins 10.
Interestingly, VZV ORF25 interacts with only four cellular proteins (unpublished results).
Recently, Visalli et al. have shown that ORF25 interacts with two components, i.e. ORF30
and ORF45/42 (HSV-1 UL28 and UL15), of the putative terminase complex by pull-down
assays in an in vitro translation system 11. Not yet well understood, however, is the linkage
between cleavage/encapsidation of viral DNA and the nuclear egress of mature capsids.Here
we investigate the interactions of all the VZV proteins that are predicted to be related to the
encapsidation process and the nuclear egress complex (NEC) by means of three independent
protein-protein interaction (PPI) detection systems: Y2H, luminescence based MBP pull-
down interaction screening (LuMPIS) and bioluminescence resonance energy transfer
(BRET) 10, 12. Furthermore, we demonstrate that ORF25 is essential for virus replication by
generating ORF25 mutant viruses using a cosmid based system.
MATERIALS AND METHODS
Recombinatorial Cloning of VZV ORFs
The nucleotide sequences of all VZV ORFs used in this study were obtained from the ncbi
(http://www.ncbi.nlm.nih.gov/). BP recombination reactions of VZV ORFs into pDONR207
(Invitrogen, Germany) were performed as described earlier 10, 13. LR recombination
reactions using LR-clonase II enzyme mix (Invitrogen, Germany) were performed according
to the manufacturers’ instructions. Briefly, pENTR207-VZV-ORF vectors containing VZV-
ORFs flanked by attL-sites were recombinatorially cloned into the attR-sites of the
customized vectors pCR3-MBP-N-[rfB], pCR3-eGFPLuc-N-[rfB] 12, pCR3-Venus-N-[rfB]
and respective BRET destination vectors with N- or C-terminal coding sequence of Renilla
luciferase (Rluc) or yellow fluorescence protein (YFP). The vector pCR3-Venus-N-[rfB] has
been constructed by insertion of a customized cassette consisting of 5′-HindIII-ATG-
[Venus]-EcoRV-[ccdB/CmR(rfB)]-EcoRV-3′ into the backbone of the pCR3 (Invitrogen,
Germany). LR clonase reactions were incubated at 37°C for 2 h and subsequently
transformed into chemically competent E. coli DH5α. Plasmid DNA of individual colonies
grown on LB-plates supplemented with 100 μg/ml ampicillin (Sigma-Aldrich, Germany)
was isolated and the integrity of the resulting pCR3- based vectors was verified by
restriction analysis.
Construction of VZV cosmids and generation of ORF25 mutant viruses
The complete genome of the parental OKA (pOKA) VZV strain has been subcloned as four
overlapping fragments within the cosmids: pvSpe14, pvFsp73, pvSpe23ΔAvrII, and
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pvPme2 14, 15. For easier handling, the pvSpe14 cosmid was split into two smaller cosmids
designated pNhe and pPvu within this work (Fig. 1, lane 3). For the construction of pNhe,
the original vector pvSpe14 was digested with NheI, treated with Klenow enzyme and
subsequently digested with AscI. The 26964bp AscI / (NheI-)blunt end fragment comprising
the VZV- specific nucleotides 1 (AscI) - 26964 (NheI) of pvSpe14 was isolated and inserted
into SuperCos vector (Stratagene, USA). For this purpose, SuperCos vector was digested
with AvrII, blunt ended with Klenow enzyme and digested with AscI. The religation of blunt
ended NheI and AvrII sites reconstituted a functional NheI site. Prior to cosmid transfections,
the SuperCos vector part of pNhe was separated from the 26964bp genomic VZV-sequence
by AscI and NheI double digest. For the construction of pPvu, the original vector pvSpe14
was digested with PvuI. The 21602bp PvuI fragment comprising the VZV-specific
nucleotides 24687 - 40080 of pvSpe14 and approximately 5000bp of its 6800bp SuperCos
vector backbone was isolated and ligated to an 1800bp, PvuI-digested PCR-fragment
designed to reconstitute the functional (full length) SuperCos vector backbone within pPvu.
The latter PCR-fragment was amplified from pvSpe14, by using the primers “45215upper”
(5′- TTCCGACCCTGCCGCTTACC-3′) and “end+PvuI lower” (5′-
TCACCGATCGGGCGCGCCGGATCCTTTAGT-3′). Prior to cosmid transfections, the
SuperCos vector part of pPvu was separated from the 15393bp genomic VZV-sequence by
AscI digest.
The strategy for the deletion of endogenous ORF25 was critical, since its reading frame
overlapped with the reading frame of ORF26 (Fig. 1, lane 4). Therefore, deletion of ORF25
was achieved by introducing the stop codon TAA at amino acid position 2, leading to a
silent mutation within ORF26. For the introduction of the respective mutation, the 4.2kb
ApaI / NheI fragment of pNhe was subcloned into the multiple cloning site of pGFP-C1
(Clontech, USA), resulting in the shuttle vector pGFP[4.2kb]. PCR mutagenesis was
performed by two rounds of PCR within the 800bp ApaI / NotI fragment of pGFP[4.2kb].
The resulting ApaI / NotI PCR fragment comprising the ORF25 deletion and its endogenous
promoter was TA-cloned into pGEM-T easy, verified by sequencing, placed back into
pGFP[4.2kb] and finally into the pNhe cosmid backbone resulting in the cosmid
pNheΔORF25 (Fig. 1, lane 4).
For the generation of pOKA-ORF25 (rescue) mutant viruses within the pOKAΔORF25
backbone, wild type ORF25 mutant and its endogenous promoter cassette was isolated as an
AvrII fragment from its respective pGEM-T easy construct and integrated into the single
AvrII site of pvSpe23ΔAvrII 15 (Fig. 1, lane 5). The cosmid pvSpe23-@ORF25-WT,
containing the wildtype ORF25 sequence was constructed analogously as control. The
integrity ofthe generated pvSpe23ΔAvrII-based (rescue) cosmids was verified by restriction
analysis and deep sequencing (LGC Genomics, Germany).
Cosmid transfections
The pvSpe23ΔAvrII-based cosmids and the other four VZV cosmids pvFsp73, pvPme2,
pPvu, and pNheΔORF25 (or pNhe), were electroporated into Top 10F’ competent cells
(Invitrogen, Germany), grown in LB containing kanamycin and ampicillin, and purified with
a NucleoBond plasmid maxi prep kit (Macherey-Nagel GmbH, Germany). Cosmids were
digested with AscI (AscI and NheI in case of pNhe or pNheΔORF25), heat inactivated for 10
min at 65°C and mixed in water to a final concentration of 100 ng/μl of pvFsp73, pvPme2,
pPvu, and pNheΔORF25 (or pNhe), and 50 ng/μl of pvSpe23ΔAvrII-based cosmid. Typical
calcium phosphate transfections were done in human MeWo cells utilizing the CalPhos™
Kit (Clontech, USA) according to the manufacturers’ instructions. After transfection, MeWo
cells were passed at a 1:3 ratio every 3 to 4 days until plaques were visible. The
reconstituted recombinant viruses were named: pOKA (derived from pvFsp73, pvPme2,
pNhe, pPvu, pvSpe23ΔAvrII) and pOKAΔORF25-R- WT (derived from pvFsp73, pvPme2,
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pNheΔORF25, pPvu, pvSpe23-@ORF25-WT. The integrity of all reconstituted viruses was
verified by sequencing (LGC Genomics, Germany).
Antiserum preparation
For the generation of a polyclonal antiserum against VZV ORF25, E. coli BL21 (Invitrogen,
Germany) were transformed with pETG-His-N-ORF25 13. His-tagged ORF25 was purified
by Ni-NTA affinity chromatography (Qiagen, Germany) and used for the immunization of
rabbits in our in house animal facility (Max von Pettenkofer Institute). Preimmune sera and
sera derived from different bleedings were analyzed by western blot and immunfluorescence
(data not shown).
Cell lines
MeWo (ATCC HTB-65) cells used for propagation of recombinant wild type and mutant
parental pOKA strains were grown in MEM (Invitrogen, Germany), supplemented with 10%
FCS (PAA, Germany), 1% non essential amino acids (Invitrogen, Germany), 100 units/ml
pencillin, 0.1 mg/ml streptomycin and fungizone (Invitrogen, Germany). Hela cells were
grown in D-MEM (Invitrogen, Germany) supplemented as described above. HEK 293 T
(ATCC CRL-11268) cells were grown in the same medium as Hela (ATCC CCL-2) but
additionally supplemented with 20 μg/ml G418 (PAA Laboratories, USA). COS7 (DSMZ
ACC 60) cells were cultured in hyperflask cell culture vessels (Corning, Germany) in RPMI
1640 with stable glutamin (4.5 g/l) (PAA, Germany) supplemented with 10 % FCS (PAA,
Germany), 100 units/ml penicillin, 0.1 mg/ml streptomycin and 0.25 μg/ml mphotecerin B
(PAA, Germany).
Immunofluorescence microscopy
To examine transfected cells by immunofluorescence microscopy, Hela cells were grown on
glass slides placed on to 12-well cell culture plates and transiently transfected with pCR3-N-
Venus-ORF25 with FugeneHD™ transfection reagent. After 48 h, the cells were fixed in
ice-cold 4% paraformaldehyde for 10 min at 4°C, DAPI stained and washed three times with
phosphate-buffer-saline (PBS). To evaluate if a second protein influenced ORF25 transient
localization, co-transfection experiments were done using pCR3-N-MBP-ORFx (x= ORF24,
ORF25, ORF26, ORF27, ORF30, ORF34, ORF45/42, ORF43, ORF46, ORF54, ORF62 and
ORF63 (IE63)) or pCR3-N-ORF63. After blocking, cells were incubated with monoclonal
anti-MBP (New England Biolabs, Germany) (1:10,000) at room temperature (RT) for 3 h on
a shaking device. Cells were washed three times with PBS at room temperature and were
incubated for 1 h with the secondary antibody (goat anti-mouse-A563, Invitrogen). Cells
were washed with PBS and slides were mounted with Vectashield (Vector Laboratories,
USA).
To examine infected cells by immunofluorescence microscopy, MeWo cells were grown in
cell culture slides and infected with recombinant pOKA viruses. Four days post-infection,
cells were fixed in 4% ice-cold paraformaldehyde for 10 min at 4°C. After fixation, a double
IF staining was carried as described above using a polyclonal ORF25 rabbit antiserum
(1:500) and a mouse monoclonal anti-IE63 (1:500) as primary antibodies and goat anti-
rabbit-A488 and anti-mouse-A563 as secondary antibodies. (1:400, Invitrogen).
For time course IF experiments, infected inoculum cells were differentiated from uninfected
cells by labelling with orange CellTracker (CMRA; Invitrogen). The orange cell tracker is
retained within the labelled cells and is not released into the medium. The uninfected Mewo
cells were seeded on the glass cover slips and were grown to 90% confluency. The
uninfected cells were infected with CMRA labelled inoculum cells with a virus titre of 4 ×
103 PFU. Inoculum cells were allowed to settle and were grown at 37°C. Cells were fixed
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with 2% formaldehyde at 2, 4, 6, 9 and 12 h. Two cover slips were examined at each time
point in all experiments, and two independent time course experiments were performed to
evaluate the kinetics of expression of each VZV protein. After fixation, IF staining was
carried as described above.
Luciferase-based detection MBP-pull down interaction screen (LuMPIS)
LuMPIS was performed as described before 12. Briefly, semiconfluent HEK 293 T cells
grown in 12-well plates were transfected with the respective prey and bait vectors using
FuGENE HD™ as transfection reagent. Transfected HEK 293 T cells were grown for 48 h
and then lysed in 500 μl lysis buffer (20 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, 0.05 %
Tween 20™, 5 μg/ml Leupeptin, 5 μg/ml DNAse I, 2.5 mg/ml BSA, pH 7.5) by sonication
(5 pulses of 15 seconds) at 4°C. Lysates were cleared by centrifugation at 13,000 g at 4°C
for 10 min and then diluted 1:10 in washing buffer (20 mM Tris-HCl, 200 mM NaCl, 1 mM
EDTA). MBP tagged bait proteins were captured by using 100 μl of pre-equilibrated 50 %
amylose beads slurry (New England Biolabs, Germany). After washing the amylose beads
four times with 200 μl washing buffer, the captured MBP tagged bait proteins were eluted
with 150 μl 10 mM maltose using a vacuum Manifold (Millipore, Germany). The co-eluted
eGFP-Luc tagged prey proteins were detected by measuring luciferase activity in 50 μl
eluate after addition of 50 μl luciferase assay reagent (Promega, Germany) using an Optima
FLUOstar Luminometer system (BMG LABTech, Germany). The Luminescence Intensity
Ratio (LIR) was calculated as LIR = (EluateeGPF-Luc tagged prey & MBP tagged bait:
LysateeGFPLuc tagged prey & MBP tagged bait) / (Eluatenegative control: LysateNegative control). The
negative control (i.e. eGFP-Luc tagged prey expression vector co-transfected with the empty
MBP vector) was performed for each prey protein. Two independent experiments (in
quaduruplicate) were done. The expression of N- eGFPLuc-tagged ORFs was tested by
inverse fluorescence microscopy before starting the cell lysis and afterwards by measuring
the luciferase activity of the lysates. In previous experiments, we have also checked by
westernblot that the corresponding N-MBP-tagged VZV ORFs were appropriately expressed
under the same experimental conditions. The data were statistically analysed by ANOVA
(P<0.05) followed by Dunnett’s post hoc test.
Bioluminescence resonance energy transfer (BRET)
BRET analysis was performed as described before 12. Briefly, binary interactions were
tested in all eight possible combinations of the proteins of interest either fused to Rluc or
YFP. All combinations were tested in duplicates and 2 independent experiments. For each
interaction, COS7 cells were co-transfected with a total of 1 μg DNA at acceptor to donor
ratios of 3:1 and incubated at 37°C. Luciferase signals were acquainted after 24 h upon
addition of coelenterazine (30 μM) as the Rluc substrate to the living cells. Light emission
was collected over 10 s at 475 nm (Rluc-signal) and 535 nm (BRET-signal). The BRET-
ratio was calculated using ((BRETprobe – Rlucprobe * cf) / Rlucprobe), where cf =
BRETcontrol / Rluccontrol is a correction factor obtained from cells expressing Rluc fusion
protein alone. Luminescence signals detected at 485 nm served as a control showing that the
proteins of interest tagged to Rluc (energy donor) are efficiently expressed. The BRET ratio
was only calculated for luminescence signals at 485 nm exceeding a background threshold
level (interval of the mean value and the ninefold standard error of a non-transfected
control). Sufficient expression of YFP tagged proteins was validated by fluorescence
microscopy following BRET measurement.
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RESULTS
Effect of ORF25 deletion on viral replication
First, we tested whether we could generate a ORF25 knock-out VZV virus mutant using an
established cosmid system14 modified in this work, however no infectious virus was
reconstituted from eight independent transfection experiments when ORF25 was deleted. In
all cases, infectious VZV was recovered when intact (wild type) ORF25 was inserted into
pvSpe23 AvrII, in the context of the genomic deletion of ORF25, or when the wildtype set
of cosmids was used, indicating that ORF25 is an essential protein for VZV replication.
Furthermore, the reconstituted revertant showed no differences in replication as compared to
the wild type, suggesting that the observed lethal phenotype of the knock-out mutant was
due to the essential character of ORF25 and not to secondary mutations (data not shown). In
addition, the ORF25 mutation did not revert to wild type as confirmed by PCR and
sequencing.
Intracellular localization of ORF25
Coverslips were seeded with MeWo cells and infected with pOKA to study the localization
of ORF25 during VZV replication using a polyclonal rabbit anti-ORF25 antibody. In the
context of viral infection at 48 h, ORF25 localized to the nucleus, forming globular domains
occupying large parts of it, which resembled the typical arrangement of replication
compartments and correlates with the localization of IE63 at early stages of infection (Fig.
2A, upper panel). In adition, ORF25 also localized diffusely to the cytoplasm. ORF25
individually expressed by transient transfection into Hela cells was localized to both the
nucleus and the cytoplasm, but rather than forming globular structures in the nucleus it
presented a diffuse localization (Fig. 2A, lower panel). When co-transfecting ORF25 with
N-MBP tagged ORFs as indicated in the methods section and in case of IE63 also with the
untagged form, no changes were observed in the transient ORF25 distribution in Hela cells
(data not shown).
ORF25 expression kinetics after infection
To investigate the kinetics of expression of ORF25, a differential labelling protocol was
used to distinguish newly infected cells from infected inoculum cells. In addition, we also
studied two well known immediate early (IE) and early proteins (E), namely IE63 and
ORF47, respectively at intervals of 4, 6, 9 and 12 h after infection (Fig. 2B). Using a regular
fluorescence microscope, the expression of both IE63 and ORF47 could be detected as early
as 4 h post infection. Both proteins showed the typical staining already described for these
proteins in the literature, with IE63 localized mainly to the nucleus and ORF47
cytoplasmatic. In contrast, ORF25 was not detected until 9 h post infection, indicating that
this protein is expressed at later stages in infection. Similarly to IE63, ORF25 also showed
nuclear staining characterized by globular domains (Fig. 2B). In addition, ORF25 could also
be clearly detected in the cytoplasm, whereas IE63 showed very weak cytoplasmatic
staining at this stage.
ORF25 self-interaction
In order to study which domains of ORF25 are responsible for self-interaction, full length
ORF25 and its N-terminal (aa 1 - 80) and C-terminal (aa 81 - 156) domains were subjected
to Y2H and LuMPIS analysis. In both assays we found that the C-terminus of ORF25 is
mainly involved in the self-interaction (Fig. 3).
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Analysis of PPI between ORF25 and VZV components of the terminase complex, NEC and
proteins involved in DNA packaging
The PPI between ORF25 and ten proteins whose orthologues in other α-herpesviruses have
been related to the encapsidation and nuclear egress process - i.e. ORF24 (UL34), ORF25
(UL33), ORF26 (UL32), ORF27 (UL31), ORF30 (UL28), ORF34 (UL25), ORF45/42
(UL15), ORF43 (UL17), ORF46 (UL14) and ORF54 (UL6) - were selected and investigated
by three independent PPI testing systems: Y2H, LuMPIS and BRET. ORF25 interacted with
seven of the proteins tested and itself in the Y2H screen 10, 16, with eight and itself in
LuMPIS and with all of them apart from ORF24 in BRET (Table 1). As a result, ORF25
interacts with itself and seven other proteins with a high fidelity score, which suggests that
ORF25 plays a central role in the encapsidation and nuclear egress process.
Comprehensive analysis of PPI between VZV components of the terminase complex, NEC
and other proteins involved in DNA packaging
For a more comprehensive analysis of PPI related to encapsidation and nuclear egress
process, ORF25 and the ten relevant VZV proteins were analyzed systematically by Y2H,
LuMPIS and BRET. VZV protein interaction screens based on Y2H analyses were recently
published by members of our group 10, 16. In the work of Stellberger et al., VZV ORFs were
cloned as N- and C-terminal fusion proteins to the Gal4DNA binding (bait) and Gal4
activation (prey) domains and tested against each other in four combinations (NN, NC, CC,
CN) using a matrix approach 10, 16. Fig. 4A summarizes the results of the 400 tested protein-
protein configurations [45 possible binary interactions × 4 possible
combinations(NN, NC, CC, CN) × 2 directions(as prey or bait) + 10 possible self interactions × 3
possible combinations(NN, NC, CC, CN) × 1 direction] among 10 ORFs analyzed within the
comprehensive Y2H screen 10, 16. In this approach, an interaction was considered positive if
at least one of the combinations was positive (depicted as a full box in the matrix chart, Fig.
4A). The Y2H analysis revealed 23 binary interactions between the ten proteins that were
tested (Fig. 4A).
The LuMPIS method is highly sensitive and can detect PPI with binding affinities of at least
10 μM12. In this assay, the ten VZV proteins were assayed as N-terminal fusion proteins
(NN). Fig. 4B summarizes the results of the 100 tested protein-protein configurations [45
possible binary interactions x 1 possible combination(NN) x 2 directions(as prey or as bait) + 10
possible self interactions x 1 possible combinations(NN)] detected by LuMPIS. The analysis
of the data generated by LuMPIS revealed 30 binary interactions between the 10 tested
proteins. Seven PPI, which were found by the permutated Y2H screen, namely ORF24-
ORF25, ORF24-ORF26, ORF24-ORF34, ORF24-ORF46, ORF30-ORF45/42, ORF34-
ORF43 and ORF45/42-ORF45/42 were not detected by LuMPIS nor BRET (Fig. 4). On the
other hand, fourteen PPI, which were not found in the Y2H screen, were detected by
LuMPIS. These interactions were ORF25-ORF54, ORF26-ORF30, ORF26-ORF34, ORF26-
ORF46, ORF26-ORF54, ORF27-ORF34, ORF27-ORF45/42, ORF30-ORF30, ORF34-
ORF27, ORF34-ORF34, ORF34-ORF54, ORF43-ORF43, ORF43-ORF54 and ORF54-
ORF54 (Fig. 4B).
In order to validate the PPI in real time in living cells, BRET was performed as described
earlier 12. For this purpose, the ten selected VZV proteins were N- and C- terminally fused
to Rluc (donor) or YFP (acceptor), respectively, and tested against each other in all possible
tag combinations. Fig. 4C summarizes the results of the 400 protein-protein configurations
[45 possible binary interactions x 4 possible combinations(NN, NC, CC, CN) × 2
directions(as donor or acceptor) + 10 possible self interactions × 4 possible
combinations(NN, NC, CN, CC) × 1 direction] tested by BRET. We considered a PPI positive
for BRET when at least one of the tested configurations was positive. Within this assay, 17
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PPI could be detected. Three of these interactions were not found in either Y2H or LuMPIS
(i.e. the ORF46 self-interaction, the ORF25-ORF46 and the ORF34-ORF46 interactions).
Noticeably, only one of the ORF45/42 interactions, namely ORF45/42-ORF25 could be
detected using this assay.
Using Y2H as the gold standard for PPI detection, we calculated the sensitivity and
specificity of LuMPIS and BRET (Supplementary Table 1). While LuMPIS had a higher
sensitivity (69.56% vs. 47.82%), BRET presented higher specificity (78.57% vs. 61.11%).
DISCUSSION
Previous studies suggested that HSV-1 UL33 is an integral component of the terminase
complex involved in the cleavage and packaging of HSV-1 DNA 4, 17. In agreement with its
postulated role in virus replication, UL33 has been shown to be essential 18. Visalli et al. 11
hypothesized that VZV ORF25 is a component of the terminase complex and we show for
the first time, that ORF25 is essential for VZV replication. The UL33 gene product is a
highly conserved protein in α-herpesviruses, with the region comprising aa 101-130 being
one of the most-well-conserved portions of the genome4. ORF25 interacts with itself via its
C- terminal domain, which comprises this conserved tegion. The fact that the ORF25 full-
length interaction was stronger than the PPI with the C-terminal domain may be due to
differences in protein folding.
HSV-1 UL33 localizes mainly to the cytoplasm when transiently expressed, and to
replication compartments in virus infected cells 4, 17. A similar behaviour was observed for
ORF25 but, in this case, a diffuse nuclear localization was also evident under transient
conditions using Venus-tagged ORF25. Furthermore, we could not find a second viral
protein that influenced ORF25 localization when transiently co-transfected (results not
shown), in contrast to the effects of UL15 of HSV-1 3 and UL14 of HSV-2 17 on UL33.
Wang et al. 19 have shown that proteins of up to about 110 kDa may diffuse through the
nuclear pores. Thus, it is possible that ORF25, which is <20 kDa, may use this mechanism
to translocate to the nucleus in the absence of an NLS.
In order to overcome the limitations due to the highly cell-associated nature of VZV, which
makes it very difficult to obtain synchronous infections, we stained the inoculum cells to
differentiate newly infected cells from inoculum using a similar approach as Reichelt et
al. 20. ORF25 was detected after IE63 and ORF47, which are considered IE and E proteins,
respectively. Reichelt et al. 20 showed that VZV DNA replication was detectable at 4 hpi
and virion assembly and envelopment by 9 hpi, which would correlate with the expression
of ORF25 and its postulated involvement in packaging the viral DNA into preformed
capsids.
LuMPIS, BRET and Y2H analysis revealed that ORF25 interacts with itself, and that the
interaction domains comprise regions in the C-terminal domain. For studying the PPI of
proteins involved or related to the encapsidation and nuclear egress process, we used three
independent systems based on different principles and host cells as a strategy to reduce false
positive and false negative rates. By doing so, we combined the advantages of each system,
which reduced the possibility that an apparent interaction was a random occurrence (i.e.
increased specificity) and also allowed the detection of interactions that might otherwise not
have been identified (i.e increased sensitivity). The detection of protein interactions between
membrane proteins is highly impaired or impossible using the Y2H system, since PPI that
activate the auxotrophy are required to occur in the nucleus 21, and proteins artificiallly
expressed in yeast may be misfolded or only partially folded. Nevertheless, Braun et al. 22
showed that Y2H is not prone to detect more false positives than other assays, and therefore
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we used it as gold standard to calculate the sensitivities and specificities of the other two
assays used here. LuMPIS showed a higher sensitivity than BRET (69.56% and 47.82%,
respectively), i.a. a higher ability to identify positive results. Recently, five different types of
assays detecting binary protein interactions were compared with a reference set of PPIs and
the highest assay sensitivity was found for LUMIER 22, which has a similar principle as
LuMPIS. Within the LuMPIS screen, we also found some novel interactions, which were
not detected by the permutated Y2H screen (Fig. 4B). One of the main reasons could be that
the transient PPI in LuMPIS is studied in the intracellular environmental context where the
interaction usually takes place, it overcomes known expression problems of VZV ORFs due
to their low GC content and also offers other advantages such as better solubilisation of the
bait and high sensitivity of detection due to the luciferase 12.
BRET is a very powerful technique for the detection of PPI in living cells. The method
overcomes the problem of false positive PPI caused by the artificial expression in the same
cellular compartment, and is particularly useful for the detection of PPIs between membrane
proteins. Bioluminescence resonance energy transfer only occurs if the acceptor-donor pair
has a distance of <10 nm, a positive BRET-signal is therefore generally indicative of a
physical interaction between proteins of interest. However, random collision of
overexpressed protein pairs may result in unspecific energy transfer detected as “bystander”
BRET signal 23, 24. Due to the dipole-dipole nature of the resonance energy transfer
mechanism, the relative orientation of the interaction partners may also affect the
signal 21, 25. Moreover, BRET tags may interfere with the interacting domains of the
proteins of interest and thus impede physiological binding. To minimize these effects, we
have tested all protein pairs in all possible configurations (Fig. 4C). BRET presented a lower
number of false positives, which results in a higher specificity (78.57%) than LuMPIS
(61.11%) (Supplementary Table 1). In total, only three interactions detected by BRET could
not be confirmed by the other two assays.
The PPI chart (Fig. 5A) depicts graphically the binary PPI identified by using three
independent systems: Y2H, LuMPIS and BRET. We considered the interactions that were
found in all three assays to be high fidelity interactions (Fig. 5A), the PPI found in two
assays as medium fidelity (Fig. 5A) and the ones found in only one of the systems as low
fidelity interactions (Fig. 5A).
Our results support the hypothesis that the terminase in VZV is a tripartite complex formed
by ORF25, ORF30 and ORF45/42 (Fig. 5A and B) similar as reported for HSV-1 9 and
PrV2, 9 . As in HSV-126 (but not PrV2), ORF30 and ORF45/42 of the VZV terminase
complex interacted with the portal protein ORF54 by Y2H and LuMPIS (Fig. 5A), In VZV,
there was an additional interaction between the terminase complex and ORF54 via ORF25,
which was detected by BRET and LuMPIS. We also detected novel interactions linking the
packaging proteins ORF34, ORF43 and ORF26 to the terminase complex (ORF34-ORF25
and ORF43- ORF25). The interaction between ORF25 and ORF43 corresponds to the
HSV-1 interaction UL33-UL1711, 27 and represents a link between the capsid and the
terminase complex as UL17 is located on the external surface of the viral capsid and thought
to stabilize the capsid or engage molecular motors for capsid transport28, 29. The interaction
between the tegument protein UL14 (ORF46) and UL33 (ORF25) described for HSV-117
was also detected in VZV by BRET (but neither Y2H nor LuMPIS). In VZV, we observed
an interaction between the terminase complex and NEC mediated by ORF25 and ORF27 by
all three types of binary interaction assays (Fig. 5A)10,16. In previous studies, multiple
additional interactions (ORF45/42-ORF27; ORF34-ORF24; ORF26-ORF24; ORF25-
ORF24) between terminase/associated proteins and NEC have been observed. The
significance of the differences between VZV and other α-herpesviruses, however, remains
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elusive, as direct conclusions can only be drawn if comparative studies were done using the
same technologies and were done in parallel.
In summary, we present evidence that ORF25 is an essential protein and represents a central
hub for the proteins involved in encapsidation and nuclear egress. In future work, it would
be important to define its specific role as component of the terminase complex, for example
as a scaffold and stabilizing component for other proteins involved in packaging and
encapsidation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Synopsis
Varicella zoster virus (VZV) ORF25 belongs to 40 core proteins conserved throughout
the Herpesviridae. We investigated the interactions of all ten VZV proteins related to the
encapsidation process and the nuclear egress complex (NEC) by three independent
protein- protein interaction (PPI) assays: Y2H, LuMPIS and BRET. We demonstrate that
ORF25 is essential for VZV replication, being a central hub linking encapsidation
proteins and the NEC.
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Fig. 1.
Construction of p-OKA cosmid vectors with VZV ORF25 deletion and substitution mutants.
Line 1 shows a schematic diagram of the pOKA genome and the localization of orf25 in the
unique long region. Line 2 depicts the overlapping segments of the pOKA genome
subcloned into the respective pOKA cosmids: pvFspe73, pvSpe14, pvSpe23, and pvPme 2.
Line 3 shows the splitting of the pvSpe14 segment into pNhe and pPvu. Line 4 shows the
construction of the orf25 deletion mutant, where the second codon of orf25 was changed
into a stop codon without affecting the integrity of the orf26 reading frame (black box). Line
5 depicts the position of the single AvrII site within pvSpe23 used for the insertion of orf25
rescue or substitution mutants. shows the construction of ORF25 mutants using a novel 5
cosmid system. Lane 1 shows the localization of ORF25 within the VZV genome and lane 2
the arrangement of the four cosmids including the whole VZV genome. Lane 3 shows how
cosmid pvSpe14 was split into two overlapping cosmids. Lane 4 depicts the construction of
the deletion mutant by introducing the stop codon TAA (black square) at aa position 2,
which results in silent mutations for the overlapped ORF26. Lane 5 depicts the ectopic AvrII
site of insertion of the rescue mutant.
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Fig. 2.
A) The upper panel shows MeWo cells that were infected with pOKA, fixed at 48 hpi and
subjected to microscopic analysis. ORF25 was detected with a rabbit polyclonal anti-
ORF25 and IE63 was detected with a mouse and nuclei were counterstained with DAPI. The
lower panel shows MeWo cells transfected with the expression plasmid pCR3.1-N-Venus-
ORF25 expressing full-length ORF25, fixed at 48 h post transfection, and subjected to
microscopic analysis. B) Kinetics of ORF25 expression in VZV infected MeWo cells. The
infected input cells were labeled with an orange cell tracker, which allows the selective
analysis of newly infected cells. MeWo cells were infected with orange CellTracker labeled,
pOKA-infected inoculum cells. The cells were fixed at 4, 6, 9 and 12 hpi and stained with
specific antibodies for VZV proteins ORF25, ORF47 or ORF63. Cell nuclei were
counterstained with DAPI. Pink arrows mark inoculum cells whereas green arrows indicate
the corresponding VZV ORF.
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Fig. 3.
Self-interaction of ORF25. This figure shows the Y2H and LuMPIS results of the ORF25
self interaction assay as studied with the full-length protein as well as with its N- and C-
terminal domains. The data were statistically analysed by ANOVA (*P<0.05) followed by
Dunnett’s post hoc test.
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Fig. 4.
PPI of proteins putatively involved in encapsidation and nuclear egress as determined by
three independent PPI screens. Panel A, B and C depict the results obtained by Y2H 10, 16,
LuMPIS and BRET, a full box represents a positive interaction, under each matrix there is a
scheme illustrating the different fusion proteins used in the respective assays. Panel D
summarizes the number of in the intersections depict the overlap between the different
screening systems.
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Fig. 5.
Model of the PPI network of proteins putatively involved in encapsidation and nuclear
egress. Panel A shows the PPI considered as high fidelity (detected by all three screen
systems) in black full lines, and those considered as medium fidelity (detected by two
systems) in full grey line if detected by Y2H and LuMPIS and in dashed lines if detected by
LuMPIS and BRET. Panel B depicts the interactions of the orthologues as already described
in the literature 2, 3, 9-11, 16, 17, 26, 27, 30-33. Full dark gray lines represent interactions
validated with other systems than Y2H and the dashed lines represent PPI found exclusively
in Y2H screens. The numbers on the lines represent respective citations 1=16, 34, 35, 2=16,
3=10, 4=3, 10, 16, 5=10, 6= 2, 11, 32, 35, 7=26, 27, 8=10, 16, 9=16, 10=11, 16, 27, 11=16, 12=16,
13=10, 14=10, 16, 15=16, 16=2, 3, 10, 11, 33, 34, 17=26, 30, 31, 18=10, 16, 30, 31, 19=10, 20=16.
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Table 1
Summary of ORF25 PPIs with proteins related to the encapsidation and nuclear egress process as determined
by three independent methods: Y2H, LuMPIS and BRET.
PPI
ORF25 vs. Y2H LuMPIS BRET Fidelity score
ORF24 + − − al
ORF25 + + + bh
ORF26 + + + h
ORF27 + + + h
ORF30 + + + h
ORF34 + + + h
ORF43 + + + h
ORF45/42 + + + h
ORF46 − − + l
ORF54 − + + cm
PPI detected were considered as al: low confident if detected by only one method, bh: highly confident if detected by all three systems and as cm:
medium confident if detected by two methods.
J Proteome Res. Author manuscript; available in PMC 2012 December 2.
